These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 32767927)

  • 1. CDKN2B-AS1: An Indispensable Long Non-coding RNA in Multiple Diseases.
    Song C; Qi Y; Zhang J; Guo C; Yuan C
    Curr Pharm Des; 2020; 26(41):5335-5346. PubMed ID: 32767927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of long non-coding RNA AFAP1-AS1 in human malignant tumors.
    Ji D; Zhong X; Jiang X; Leng K; Xu Y; Li Z; Huang L; Li J; Cui Y
    Pathol Res Pract; 2018 Oct; 214(10):1524-1531. PubMed ID: 30173945
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Luo Y; Tao H; Jin L; Xiang W; Guo W
    Cancer Biother Radiopharm; 2020 Feb; 35(1):58-65. PubMed ID: 31724892
    [No Abstract]   [Full Text] [Related]  

  • 4. LncRNA CDKN2B-AS1 promotes the progression of ovarian cancer by miR-143-3p/SMAD3 axis and predicts a poor prognosis.
    Xu C; Zhai J; Fu Y
    Neoplasma; 2020 Jul; 67(4):782-793. PubMed ID: 32305052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long non-coding RNA CDKN2B-AS1 reduces inflammatory response and promotes cholesterol efflux in atherosclerosis by inhibiting ADAM10 expression.
    Li H; Han S; Sun Q; Yao Y; Li S; Yuan C; Zhang B; Jing B; Wu J; Song Y; Wang H
    Aging (Albany NY); 2019 Mar; 11(6):1695-1715. PubMed ID: 30926762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long non-coding RNA CDKN2B-AS1 contributes to atherosclerotic plaque formation by forming RNA-DNA triplex in the CDKN2B promoter.
    Ou M; Li X; Zhao S; Cui S; Tu J
    EBioMedicine; 2020 May; 55():102694. PubMed ID: 32335370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpressed lncRNA CDKN2B-AS1 is an independent prognostic factor for liver cancer and promotes its proliferation.
    Zhuang H; Cao G; Kou C; Li D
    J BUON; 2019; 24(4):1441-1448. PubMed ID: 31646789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DLX6-AS1: An Indispensable Cancer-related Long Non-coding RNA.
    Hu C; Liu K; Wang B; Xu W; Lin Y; Yuan C
    Curr Pharm Des; 2021; 27(9):1211-1218. PubMed ID: 33121401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Linear and circular CDKN2B-AS1 expression is associated with Inflammatory Bowel Disease and participates in intestinal barrier formation.
    Rankin CR; Lokhandwala ZA; Huang R; Pekow J; Pothoulakis C; Padua D
    Life Sci; 2019 Aug; 231():116571. PubMed ID: 31207308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NR2F1-AS1: A Functional Long Noncoding RNA in Tumorigenesis.
    Hu J; Peng F; Qiu X; Yang J; Li J; Shen C; Yuan C
    Curr Med Chem; 2023; 30(37):4266-4276. PubMed ID: 36644870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA SBF2-AS1: A Budding Star in Various Cancers.
    Tan F; Chen J; Wang B; Du Z; Mou J; Wu Y; Liu Y; Zhao F; Yuan C
    Curr Pharm Des; 2022; 28(18):1513-1522. PubMed ID: 35440300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Knockdown of long non-coding RNA TP73-AS1 inhibits cell proliferation and induces apoptosis in esophageal squamous cell carcinoma.
    Zang W; Wang T; Wang Y; Chen X; Du Y; Sun Q; Li M; Dong Z; Zhao G
    Oncotarget; 2016 Apr; 7(15):19960-74. PubMed ID: 26799587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long non-coding RNA CDKN2B-AS1 promotes osteosarcoma by increasing the expression of MAP3K3 via sponging miR-4458.
    Gui D; Cao H
    In Vitro Cell Dev Biol Anim; 2020 Jan; 56(1):24-33. PubMed ID: 31950433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ZFPM2-AS1: An Oncogenic Long Non-coding RNA in Multiple Cancer Types.
    Tan F
    Mini Rev Med Chem; 2023; 23(1):88-98. PubMed ID: 35578882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long Non-Coding RNA CDKN2B-AS1 Facilitates Laryngeal Squamous Cell Cancer Through Regulating miR-497/CDK6 Pathway.
    Cui X; Yu T; Shang J; Xiao D; Wang X
    Onco Targets Ther; 2019; 12():8853-8862. PubMed ID: 31754305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DLEU1: A Functional Long Noncoding RNA in Tumorigenesis.
    Song C; Zhang J; Zhao Z; Yang Y; Meng D; Wang J; Guo C; Yuan C
    Curr Pharm Des; 2020; 26(15):1742-1748. PubMed ID: 31969095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. β-Elemene inhibits the proliferation of esophageal squamous cell carcinoma by regulating long noncoding RNA-mediated inhibition of hTERT expression.
    Hu Z; Wu H; Li Y; Hou Q; Wang Y; Li S; Xia B; Wu S
    Anticancer Drugs; 2015 Jun; 26(5):531-9. PubMed ID: 25646744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNA MNX1-AS1 promotes progression of esophageal squamous cell carcinoma by regulating miR-34a/SIRT1 axis.
    Chu J; Li H; Xing Y; Jia J; Sheng J; Yang L; Sun K; Qu Y; Zhang Y; Yin H; Wan J; He F
    Biomed Pharmacother; 2019 Aug; 116():109029. PubMed ID: 31170665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p53-induced long non-coding RNA PGM5-AS1 inhibits the progression of esophageal squamous cell carcinoma through regulating miR-466/PTEN axis.
    Zhihua Z; Weiwei W; Lihua N; Jianying Z; Jiang G
    IUBMB Life; 2019 Oct; 71(10):1492-1502. PubMed ID: 31185143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long Noncoding RNA CDKN2B-AS1 Facilitates Lung Cancer Development Through Regulating miR-378b/NR2C2.
    Wang G; Xu G; Wang W
    Onco Targets Ther; 2020; 13():10641-10649. PubMed ID: 33116641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.